Skip to main content

Together we are beating cancer

Donate now

Cervical cancer

Cervical cancer is more common in younger women, with around 3,200 people diagnosed in the UK each year. It develops in the lining of the cervix – the lower part of the womb – and the main symptom is unusual or unexplained vaginal bleeding.
Showing 12 out of 120 results
Two researchers smiling as they work together in a lab

2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023. 2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023.

by Jacob Smith | In depth | 18 December 2023

18 December 2023

Scientist preparing microscope slides with liquid based cytology method for pap smear test. Cervical cancer concept.

A new study funded by Cancer Research UK has revealed a gap in many women’s understanding of HPV (human papillomavirus) and its role in cervical screening. A new study funded by Cancer Research UK has revealed a gap in many women’s understanding of HPV (human papillomavirus) and its role in cervical screening.

by Sophie Wedekind | News | 25 October 2023

25 October 2023

A transgender woman in a hospital gown speaking to her doctor, a transgender man, in an exam room.

Charities, research institutes and health providers across the UK are working to improve LGBTQIA+ cancer care. Here's how. Charities, research institutes and health providers across the UK are working to improve LGBTQIA+ cancer care. Here's how.

by Tim Gunn | Analysis | 23 June 2023

23 June 2023

Vaccine vial and needle

Children in England will need only one dose of the HPV vaccine to prevent cervical and other related cancers from September 2023. Children in England will need only one dose of the HPV vaccine to prevent cervical and other related cancers from September 2023.

by In collaboration with PA Media Group | News | 21 June 2023

21 June 2023

A magnified image of squamous cell carcinoma, the most common type of cervical cancer

The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It's now an approved treatment for them in England and Scotland. The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It's now an approved treatment for them in England and Scotland.

by Tim Gunn | News | 16 May 2023

16 May 2023

Two of our Cancer Awareness Nurses at a stop of our Cancer Awareness Roadshow

Our nurses have answered some of the frequently asked questions they hear on our Cancer Awareness Roadshow and at Cancer Awareness in the Workplace sessions. Our nurses have answered some of the frequently asked questions they hear on our Cancer Awareness Roadshow and at Cancer Awareness in the Workplace sessions.

by Sophie Marshall | In depth | 2 March 2023

2 March 2023

A bottle containing the HPV vaccine

From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back. From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back.

by Lilly Matson | In depth | 21 November 2022

21 November 2022

This entry is part 1 of 3 in the series CRUK Global

Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician. Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician.

by Lilly Matson | Analysis | 27 April 2022

27 April 2022

A 3d rendered image of HPV cells

Wales announced changes to their routine cervical screening programme this week, moving from 3 to 5 years. We look at the science behind the switch. Wales announced changes to their routine cervical screening programme this week, moving from 3 to 5 years. We look at the science behind the switch.

by Alice Davies | Analysis | 7 January 2022

7 January 2022